Meeder Asset Management Inc Editas Medicine, Inc. Transaction History

Meeder Asset Management Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$26.55 - $40.57 $83,446 - $127,511	-3,143 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$39.27 - $72.94 $51,875 - $96,353	1,321 Added 72.5%	3,143 $129,000
Q2 2021 Aug 09, 2021	SELL	$31.29 - $56.64 $250 - $453	-8 Reduced 0.44%	1,822 $103,000
Q1 2021 Apr 28, 2021	BUY	$39.71 - $90.58 $72,669 - $165,761	1,830 New	1,830 $77,000
Q4 2020 Feb 09, 2021	SELL	$27.07 - $84.35 $164,883 - $513,775	-6,091 Closed	0 $0
Q3 2020 Nov 02, 2020	BUY	$28.06 - $37.16 $170,773 - $226,155	6,086 Added 121720.0%	6,091 $170,000
Q2 2020 Aug 11, 2020	SELL	$18.5 - $34.34 $11,988 - $22,252	-648 Reduced 99.23%	5 $0
Q1 2020 May 15, 2020	BUY	$14.88 - $32.78 $967 - $2,130	65 Added 11.05%	653 $13,000
Q4 2019 Feb 13, 2020	BUY	$19.49 - $32.63 $11,460 - $19,186	588 New	588 $17,000
Q3 2019 Oct 17, 2019	SELL	$22.49 - $26.81 $2,653 - $3,163	-118 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$20.48 - $27.76 $2,416 - $3,275	118 New	118 $3,000
Q1 2019 Apr 16, 2019	SELL	$19.43 - $26.41 $11,094 - $15,080	-571 Closed	0 $0
Q4 2018 Jan 17, 2019	BUY	$18.19 - $31.79 $10,386 - $18,152	571 New	571 $13,000
Q3 2018 Nov 02, 2018	SELL	$27.65 - $38.39 $5,447 - $7,562	-197 Closed	0 $0
Q2 2018 Jul 24, 2018	BUY	$31.4 - $41.01 $2,512 - $3,280	80 Added 68.38%	197 $0
Q1 2018 May 03, 2018	SELL	$29.84 - $44.08 $4,953 - $7,317	-166 Reduced 58.66%	117 $4,000
Q4 2017 Feb 02, 2018	BUY	$21.89 - $31.34 $6,194 - $8,869	283	283 $8,000

248

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $102M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.